Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
-
- Farnaz Foolad
- Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston
-
- Samuel L Aitken
- Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston
-
- Terri Lynn Shigle
- Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston
-
- Amrita Prayag
- Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston
-
- Shashank Ghantoji
- Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston
-
- Ella Ariza-Heredia
- Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston
-
- Roy F Chemaly
- Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston
書誌事項
- 公開日
- 2018-09-08
- 権利情報
-
- https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
- DOI
-
- 10.1093/cid/ciy760
- 公開者
- Oxford University Press (OUP)
この論文をさがす
収録刊行物
-
- Clinical Infectious Diseases
-
Clinical Infectious Diseases 68 (10), 1641-1649, 2018-09-08
Oxford University Press (OUP)
